One year ago, the American Society for Clinical Investigation (ASCI) launched JCI Insight. I am pleased to report that the last year has been a resounding success for the Society’s newest journal. Let me begin with some background. In my inaugural editorial, I laid out the rationale for JCI Insight (1). In brief, its mission is two-fold: to provide an additional forum for ASCI members and other...

The members of the Editorial Board and I welcome you to the ® rst issue of Sarcoma. This is a specialist journal that I hope will meet the needs of all who are interested in this group of diseases. The aim of this journal is to provide a focus and forum for all involved in sarcoma research. This includes scientists and clinicians and stretches from molecular biology through pathology, radiology...